Why the study?
The Ross procedure offers an alternative to prosthetic aortic valve replacement that avoids bioprosthetic degeneration and mechanical valve complications, though critics remain concerned about higher perioperative risk and potential reintervention on the pulmonary autograft and homograft.
Population
Patients with aortic valve disease
Design
State-of-the-art review
Answers are grounded in this paper and cite their sources.
Review evaluates the clinical utility of the Ross procedure in aortic valve disease, highlighting near-normal life expectancy alongside risks of reintervention and perioperative complications.
The Ross procedure is an alternative to prosthetic aortic valve replacement in patients with aortic valve disease. Proponents of the Ross procedure argue that it is associated with life expectancy close to that of the general population in patients with aortic valve disease due to avoiding the major pitfalls of both biologic (valve degeneration) and mechanical (valve-related thrombotic complications and bleeding associated with lifelong anticoagulation) prostheses.1 Critics remain concerned about higher perioperative risk and the potential need for reintervention on the pulmonary autograft and homograft. This paper reviews the existing literature and provides expert recommendations on patient selection and preoperative and postoperative care of the Ross patient.
No takes yet. Share an insight, caveat, or question.
Eikelboom et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: